DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Schwabl P, Hambruch E, Seeland BA. , et al.
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.
J Hepatol 2017;
66 (04) 724-733
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.